Nosocomial infections caused by Acinetobacter baumannii: A major threat worldwide

Infection Control and Hospital Epidemiology

Volumn 27, Issue 7, 2006, Pages 645-646

  Richet, Hervé ^a   Fournier, Pierre Edouard ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ANTIBIOTIC RESISTANCE; EDITORIAL; HOSPITAL INFECTION; HUMAN; MEDICAL LITERATURE; NEISSERIACEAE; PHENOTYPE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CROSS INFECTION; HUMANS; PHYLOGENY;

EID: 33747636495     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/505900     Document Type: Editorial

References (23)

1. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003; 24:284-295.
2. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 1999; 281:67-71.
3. Euzéby JP. List of prokaryotic names with standing in nomenclature-genus Acinetobacter. Available at: http://www.bacterio.cict.fr/a/ acinetobacter.html. Accessed June 1, 2006.
4. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004; 3:14.
5. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other non-fermentative gram-negative rods. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology. Washington, DC: ASM Press; 2003:749-779.
6. Fillaux J, Dubouix A, Conil JM, Laguerre J, Marty N. Retrospective analysis of multidrug-resistant Acinetobacter baumannii strains isolated during a 4-year period in a university hospital. Infect Control Hosp Epidemiol 2006; 27:647-653 (in this issue).
7. Wilks M, Wilson A, Warwick S, et al. Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006; 27:654-658 (in this issue).
8. Griffith ME, Ceremuga J, Ellis MW, Guymon CH, Hospenthal DR, Murray CK. Acinetobacter skin colonization of US Army soldiers. Infect Control Hosp Epidemiol 2006; 27:659-661 (in this issue).
9. Peleg AY, Franklin C, Bell J, Spelman DW. Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia. Infect Control Hosp Epidemiol 2006; 27:759-761 (in this issue).
10. Seifert H, Boullion B, Schulze A, Pulverer G. Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect Control Hosp Epidemiol 1994; 15:520-528.
11. Devaud M, Kayser FH, Bachi B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother 1982; 22:323-329.
12. Segal H, Thomas R, Gay EB. Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii. Plasmid 2003; 49:169-178.
13. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003; 41:3542-3547.
14. Fournier PE, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2:e7.
15. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9:148-165.
16. Van Looveren M, Goossens H. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004; 10:684-704.
17. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8:321-331.
18. Brown S, Young HK, Amyes SG. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005; 11:15-23.
19. Brown S, Amyes SG. The sequences of seven class D beta-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents. Clin Microbiol Infect 2005; 11:326-329.
20. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692-699.
21. Landman D, Quale JM, Mayorga D, et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 2002; 162:1515-1520.
22. Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:1063-1066.
23. Tong MJ. Septic complications of war wounds. JAMA 1972; 219:1044-1047.